Lista de obras - K Höglund - Dominio Público Uruguay

5-HT1B and other related serotonergic proteins are altered in APPswe mutation.

artículo científico publicado en 2015

A Season of American Football Is Not Associated with Changes in Plasma Tau.

artículo científico publicado en 2017

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.

artículo científico publicado en 2018

Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay

artículo científico publicado en 2017

Acute symptomatic seizures and epilepsy after mechanical thrombectomy

artículo científico publicado en 2019

Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria

artículo científico publicado en 2015

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase

scholarly article by Bruno Becker published in August 2018

An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.

artículo científico publicado en 2015

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

scientific article published on 22 April 2020

Apolipoprotein E polymorphism in patients with cataract

artículo científico publicado en 2004

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

scientific article published on 01 March 2019

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein

Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers

artículo científico publicado en 2016

Astroglial activation and altered amyloid metabolism in human repetitive concussion

artículo científico publicado en 2017

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

artículo científico publicado en 2020

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

artículo científico publicado en 2013

Cerebrospinal fluid markers of extracellular matrix remodeling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy

artículo científico publicado en 2018

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

artículo científico publicado en 2018

Characterization of tau in cerebrospinal fluid using mass spectrometry

artículo científico publicado en 2008

Characterization of the effect of a novel γ-secretase modulator on Aβ: a clinically translatable model.

artículo científico publicado en 2014

Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

artículo científico publicado en 2018

Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

artículo científico publicado en 2004

Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies

artículo científico publicado en 2015

Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease

artículo científico publicado en 2007

Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease

artículo científico publicado en 2006

Expanding the cerebrospinal fluid endopeptidome

artículo científico publicado en 2017

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

artículo científico publicado en 2018

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

artículo científico publicado en 2012

Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome

artículo científico publicado en 2007

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

scholarly article by Nicholas J Ashton et al published 9 January 2019 in Acta neuropathologica communications

Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry.

artículo científico publicado en 2012

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease

artículo científico publicado en 2012

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease

Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury

artículo científico publicado en 2004

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

artículo científico publicado en 2003

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia

artículo científico publicado en 2013

Molecular biomarkers of neurodegeneration

artículo científico publicado en 2013

Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury

artículo científico publicado en 2016

Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke

artículo científico publicado en 2018

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.

artículo científico publicado en 2018

Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease

artículo científico publicado en 2016

Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins

artículo científico publicado en 2004

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

artículo científico publicado en 2017

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides

artículo científico publicado en 2008

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems

artículo científico publicado en 2018

Publisher Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

scholarly article by Kina Höglund et al published 19 November 2018 in Translational Psychiatry

Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels

artículo científico publicado en 2005

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest

artículo científico publicado en 2019

Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease

artículo científico publicado en 2014

Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease

artículo científico publicado en 2005

Synaptic proteins in CSF relate to Parkinson's disease stage markers

artículo científico publicado en 2017

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

artículo científico publicado en 2016

Tau Diagnostics and Clinical Studies.

artículo científico publicado en 2017

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

artículo científico publicado en 2005

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease

scientific article published on 22 September 2018

Update on biomarkers for amyloid pathology in Alzheimer's disease

artículo científico publicado en 2018

Lista de obras de K Höglund

5-HT1B and other related serotonergic proteins are altered in APPswe mutation.

A Season of American Football Is Not Associated with Changes in Plasma Tau.

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.

Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay

Acute symptomatic seizures and epilepsy after mechanical thrombectomy

Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase

An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

Apolipoprotein E polymorphism in patients with cataract

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein

Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers

Astroglial activation and altered amyloid metabolism in human repetitive concussion

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

Cerebrospinal fluid markers of extracellular matrix remodeling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

Characterization of tau in cerebrospinal fluid using mass spectrometry

Characterization of the effect of a novel γ-secretase modulator on Aβ: a clinically translatable model.

Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies

Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease

Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease

Expanding the cerebrospinal fluid endopeptidome

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry.

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease

Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia

Molecular biomarkers of neurodegeneration

Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury

Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.

Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease

Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems

Publisher Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest

Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease

Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease

Synaptic proteins in CSF relate to Parkinson's disease stage markers

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

Tau Diagnostics and Clinical Studies.

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease

Update on biomarkers for amyloid pathology in Alzheimer's disease